Navigation Links
Study finds women seek anti-aging clinicians to treat menopausal symptoms
Date:8/17/2014

Feeling that conventional doctors did not take their suffering seriously, women instead sought out hormonal treatments for menopausal symptoms from anti-aging clinicians, according to a Case Western Reserve University study that investigated the appeal of anti-aging medicine.

Some women also feared the harmful side effects from conventional hormone replacement therapy (HRT) that had shown increased risks for cancer, heart disease and high blood pressure. Yet, they thought that the bioidentical, "natural" hormones their anti-aging doctors prescribed were safe, despite a lack of conventional scientific evidence to that fact.

Michael Flatt, a doctoral candidate in sociology at Case Western Reserve University, and Jennifer Fishman, assistant professor at McGill University, will discuss these and other findings during the presentation "'Hormones Are Where It's At': Bioidentical Hormones, Menopausal Women, and Anti-Aging Medicine" on Monday, Aug. 18, at the 109th Annual Meeting of the American Sociological Association, Aug. 16-19, in San Francisco.

The findings about the women's attitudes are part of a larger study in the Department of Bioethics at Case Western Reserve that investigated the views of scientists, doctors and patients involved with anti-aging science and medicine.

The researchers, who conducted the study with Richard Settersten Jr., professor of public health at Oregon State University, explored what it was about anti-aging medicine that appealed to women, given that the costs for care and prescribed medications were not covered by medical insurance.

Was it vanity to maintain their youthful appearance or some other motivation?

Findings from in-depth interviews with 25 women who used bioidentical hormone replacement therapy (BHRT) prescribed by an anti-aging clinician bucked the vanity-driven stereotype.

Instead, Flatt said the women told researchers they wanted to relieve their menopausal symptoms, feel energized and avoid chronic illnesses associated with aging. The women also described their motivation as wanting to return to an "optimal" state and believed that bioidentical hormones would do this.

"Hormones became the panacea reported by the women," Flatt said. "They felt that if the hormones were in order, they'd be back on track."

The anti-aging clinicians prescribed BHRT after the women took a series of tests to determine the causes of their menopausal symptoms, which purportedly included hormonal and vitamin deficiencies. They were prescribed BHRT, hormones derived from plants, like soy and yams. The hormonal therapies are unregulated by the Food and Drug Administration and made to order by compounding pharmacists.

Among the reasons the women said they found anti-aging medicine attractive were:

  • Patients received more time and attention from the clinician.
  • Medications were seen as "natural" and thought to return one to an optimal state of being.
  • BHRT was perceived as safer than conventional hormone replacement therapy.

'/>"/>
Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: